Nuvve (NVVE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
15 Jun, 2026Executive summary
A special meeting of stockholders was convened on June 15, 2026, but was adjourned due to lack of quorum.
The meeting is rescheduled for June 23, 2026, at 1 p.m. Eastern Time to allow more time for proxy solicitation.
The record date for voting eligibility remains April 17, 2026.
Previously submitted proxies will remain valid unless revoked or changed by stockholders.
Stockholders are urged to vote promptly to ensure their votes are counted at the reconvened meeting.
Voting matters and shareholder proposals
Proposals to be voted on were set forth in the definitive proxy statement filed on May 29, 2026.
No voting occurred at the initial meeting due to insufficient quorum.
Stockholders who have not voted or wish to change their vote are encouraged to do so before June 23, 2026.
Board of directors and corporate governance
The meeting and adjournment were conducted in accordance with the company's Amended and Restated Bylaws.
The report was signed by the Chief Executive Officer, Gregory Poilasne, on June 15, 2026.
Latest events from Nuvve
- Special meeting adjourned for lack of quorum; reconvened for June 15, 2026, with voting ongoing.NVVE
Proxy filing9 Jun 2026 - Key votes include a reverse stock split and Omnia-related share issuance leading to a change of control.NVVE
Proxy filing29 May 2026 - Key votes include a reverse stock split and Omnia share issuance, both Board-recommended.NVVE
Proxy filing19 May 2026 - Revenue and margins rose, but inventory impairment drove a higher net loss in Q4 2025.NVVE
Q4 202531 Mar 2026 - Revenue fell 62% in Q2 2024, but net loss narrowed and liquidity risks remain.NVVE
Q2 20241 Feb 2026 - Net loss narrowed to $1.65M in Q3 2024 as costs fell and margins improved.NVVE
Q3 202414 Jan 2026 - Registration of 42M+ shares for resale may cause significant dilution and price volatility.NVVE
Registration Filing9 Jan 2026 - Revenue fell in 2024, but cost cuts and backlog growth support a positive 2025 outlook.NVVE
Q4 202425 Dec 2025 - Registering 341,148 shares for resale after a $250,000 convertible note and warrant financing.NVVE
Registration Filing16 Dec 2025